<DOC>
	<DOCNO>NCT00319059</DOCNO>
	<brief_summary>Previous epidemiological study show cardiovascular patient , 34C &gt; T variant gene encode enzyme Adenosine Mono Phosphate Deaminase ( AMPD1 ) associate prolonged survival . The 34 C &gt; T variant encode severely truncate , metabolically inactive protein . We hypothesize ischemia , patient AMP preferentially convert adenosine instead IMP . Adenosine receptor stimulation , turn , increase resistance ischemia-reperfusion myocardial tissue . To test hypothesis , 7 male healthy volunteer heterozygous 34C &gt; T variant select 100 healthy volunteer , previously genotyped . These subject compare 7 match control subject . Individual ischemic tolerance assess thenar muscle use 99mTc-Annexin A5 scintigraphy . Briefly , circulation nondominant forearm interrupt 10 minute inflation upperarm cuff 200mmHg en concomitantly , subject perform isometric rhythmic handgripping exhaustion . Immediately upon reperfusion , 400 MBq 99mTc-Annexin A5 administer intravenously . Finally , 1 4 hour post-injection , scintigrapghi image hand perform . Targeting annexin A5 express percentage difference experimental control hand .</brief_summary>
	<brief_title>The Influence 34C &gt; T Variant AMPD1 Gene Ischemic Tolerance</brief_title>
	<detailed_description />
	<mesh_term>Ischemia</mesh_term>
	<mesh_term>Annexin A5</mesh_term>
	<criteria>male 1840 year healthy AMPD1 34C &gt; T variant ( heterozygous ) match control cardiovascular / pulmonary disease diabetes / hypertension</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>April 2016</verification_date>
</DOC>